Prospective Validation of the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) Score for Necrotizing Fasciitis of the Extremities.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 18 04 2019
accepted: 27 12 2019
entrez: 25 1 2020
pubmed: 25 1 2020
medline: 17 4 2020
Statut: epublish

Résumé

The Laboratory Risk Indicator for Necrotizing Fasciitis score was developed as a clinical decision tool for distinguishing necrotizing fasciitis from other soft tissue infections. We prospectively evaluated the performance of the Laboratory Risk Indicator for Necrotizing Fasciitis score for the diagnosis of patients with necrotizing fasciitis in the extremities. We conducted a prospective and observational cohort study of emergency department patients with necrotizing fasciitis or severe cellulitis in the extremities between April 2015 and December 2016. The Laboratory Risk Indicator for Necrotizing Fasciitis score was calculated for every enrolled patient. The sensitivity, specificity, positive predictive value, and negative predictive value of cut-off scores of 6 and 8 were evaluated. The accuracy of the Laboratory Risk Indicator for Necrotizing Fasciitis score was expressed as the area under the receiver operating characteristic curve. A total of 106 patients with necrotizing fasciitis and 825 patients with cellulitis were included. With an Laboratory Risk Indicator for Necrotizing Fasciitis cut-off score ≥6, the sensitivity was 43% (95% confidence interval 34% to 53%), specificity was 83% (95% confidence interval 80% to 86%), positive predictive value was 25% (95% confidence interval 20% to 30%), and negative predictive value was 92% (95% confidence interval 91% to 93%); with an Laboratory Risk Indicator for Necrotizing Fasciitis cut-off score ≥8, the sensitivity was 27% (95% confidence interval 19% to 37%), specificity was 93% (95% confidence interval 91% to 94%), positive predictive value was 33% (95% confidence interval 25% to 42%), and negative predictive value was 91% (95% confidence interval 90% to 92%). The area under the receiver operating characteristic curve for accuracy of the Laboratory Risk Indicator for Necrotizing Fasciitis score was 0.696 (95% CI 0.640 to 0.751). The Laboratory Risk Indicator for Necrotizing Fasciitis score may not be an accurate tool for necrotizing fasciitis risk stratification and differentiation between severe cellulitis and necrotizing fasciitis in the emergency department setting based on our study.

Identifiants

pubmed: 31978094
doi: 10.1371/journal.pone.0227748
pii: PONE-D-19-10946
pmc: PMC6980593
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0227748

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Injury. 2016 Sep;47 Suppl 3:S66-S71
pubmed: 27692110
J Emerg Med. 2014 Aug;47(2):172-5
pubmed: 24560016
Malays Orthop J. 2017 Jul;11(2):36-39
pubmed: 29021877
PLoS One. 2015 Jul 21;10(7):e0132775
pubmed: 26196941
West J Emerg Med. 2016 May;17(3):333-6
pubmed: 27330667
J Am Acad Dermatol. 2015 Dec;73(6):1006-12.e8
pubmed: 26412163
J Bone Joint Surg Am. 2003 Aug;85(8):1454-60
pubmed: 12925624
Ann R Coll Surg Engl. 2017 May;99(5):341-346
pubmed: 28462647
Anaesth Intensive Care. 2009 Jul;37(4):588-92
pubmed: 19681416
J Plast Reconstr Aesthet Surg. 2013 Dec;66(12):1712-6
pubmed: 23911720
ANZ J Surg. 2018 Jan;88(1-2):E45-E49
pubmed: 28296037
Radiology. 2011 Jun;259(3):816-24
pubmed: 21406630
ANZ J Surg. 2016 Oct;86(10):826-830
pubmed: 26211758
Ann R Coll Surg Engl. 2013 Jan;95(1):57-60
pubmed: 23317730
Radiol Med. 2016 Feb;121(2):106-21
pubmed: 26286006
Ann Med Surg (Lond). 2015 Sep 14;4(4):355-60
pubmed: 26568823
J Plast Reconstr Aesthet Surg. 2015 Mar;68(3):304-11
pubmed: 25444278
Infect Dis (Lond). 2015 May;47(5):319-25
pubmed: 25715941
West J Emerg Med. 2017 Jun;18(4):684-689
pubmed: 28611889
Ann Surg. 2019 Jan;269(1):58-65
pubmed: 29672405
Int Urol Nephrol. 2015 Feb;47(2):243-8
pubmed: 25503448
Br J Radiol. 2014 Jan;87(1033):20130560
pubmed: 24288403
Crit Care Med. 2004 Jul;32(7):1535-41
pubmed: 15241098
N Engl J Med. 2017 Dec 7;377(23):2253-2265
pubmed: 29211672
J Plast Reconstr Aesthet Surg. 2017 Jan;70(1):141-143
pubmed: 27297690
Am J Emerg Med. 2008 Feb;26(2):170-5
pubmed: 18272096

Auteurs

Cheng-Ting Hsiao (CT)

Department of Emergency Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan.
School of Medicine, Chang Gung University, Taoyuan, Taiwan.

Chia-Peng Chang (CP)

Department of Emergency Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan.

Tsung-Yu Huang (TY)

Division of Infectious Diseases, Department of Internal Medical, Chang Gung Memorial Hospital, Chiayi, Taiwan.

Yi-Chuan Chen (YC)

Department of Emergency Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Department of Nursing, Chang Gung University of Science and Technology Chiayi Campus, Chiayi, Taiwan.

Wen-Chih Fann (WC)

Department of Emergency Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH